KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Return on Invested Capital (2022 - 2025)

Pacific Biosciences Of California (PACB) has 4 years of Return on Invested Capital data on record, last reported at 26.75% in Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 2576.0% year-over-year to 26.75%; the TTM value through Dec 2025 reached 26.75%, down 2576.0%, while the annual FY2025 figure was 2.17%, 138.0% down from the prior year.
  • Return on Invested Capital reached 26.75% in Q4 2025 per PACB's latest filing, down from 13.66% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.28% in Q2 2022 and bottomed at 26.75% in Q4 2025.
  • Average Return on Invested Capital over 4 years is 4.72%, with a median of 0.8% recorded in 2024.
  • Peak YoY movement for Return on Invested Capital: rose 11bps in 2023, then crashed -2576bps in 2025.
  • A 4-year view of Return on Invested Capital shows it stood at 0.44% in 2022, then grew by 5bps to 0.41% in 2023, then plummeted by -140bps to 0.99% in 2024, then tumbled by -2603bps to 26.75% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 26.75% in Q4 2025, 13.66% in Q3 2025, and 9.02% in Q2 2025.